Share this
how therapeutic drug monitoring helps mental health treatment
by Neoteryx Microsampling on Feb 22, 2021 9:00:00 AM
Therapeutic drug monitoring (TDM) helps in managing patients who are undergoing psycho-pharmacotherapy. TDM is essential in preventing therapeutic nonresponse and adverse drug reactions. It also enables dose adjustment, determination of drug adherence and monitoring of pharmacokinetic drug-drug interactions.
The process of measuring therapeutic drug levels in patients is typically performed through routine blood draws and the quantification of blood, plasma or serum concentrations for dose optimization.
As the awareness of the importance of personalized treatment has increased, TDM has become essential. TDM acts as a tool that helps practitioners apply precision medicine. In neurology and psychiatry, the process is used in several patient subgroups taking therapeutic drugs:
- Adolescents
- Children
- Elderly
- Mental health patients
- Pregnant women
Therapeutic Drug Monitoring and Mental Health
Therapeutic drug monitoring for patients taking medications for mental health issues is crucial, as it ensures they receive the greatest benefit from their medical therapy. Patients with mental conditions like bipolar disorder and depression often require medications that can, unfortunately, cause negative side effects.
However, because these medications can also be quite beneficial, it is important to find the correct dose for each unique patient to avoid problems. Monitoring of drug concentration levels in a person's blood can help determine which dosing is correct for their medical benefit, while also preventing toxicity and side-effects.
Routine TDM helps providers detect any drug-related complications at an early stage before they become severe. TDM is more than just measuring the drug concentrations in blood, serum, or plasma to establish a correlation between the desired or adverse effects and dosage in the blood. It also helps healthcare providers identify failed therapy with a particular medication, and then devise a more successful treatment plan with a different medication.
Drug Monitoring for Mental Health Interventions
Drug monitoring in mental health treatment is partly conducted through blood testing to determine a drugs’ specific concentration in a person's system — often at different time points. Unfortunately, consistent blood draws may be uncomfortable or stressful, and can also put some patients at-risk for blood loss. To prevent these problems, mental health providers can use less invasive blood collection techniques like microsampling, which requires only a few drops of blood.
Patients in a remote patient monitoring program can easily use portable microsampling devices to self-collect blood samples and send them to their care provider or lab. Once physicians receive their patient's lab results, they can follow-up via video chat, phone, or email to discuss any necessary changes in care. The portability of such tools makes them easy to use, handle, and carry around.
Importance of Blood Testing in Mental Health
Blood testing for drug monitoring is fast becoming crucial in mental health treatment where therapeutic drugs are needed. Blood test results help physicians assess the right dosage for patients, monitor their adherence to a medical treatment plan, and identify failed therapy. Drug monitoring is also vital in preventing toxicity arising from the use of antidepressants and mood stabilizers that may have negative side effects at certain doses.
Share this
- Microsampling (206)
- Research, Remote Research (118)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Pharmaceuticals, Drug Development (9)
- Harpera® Tool (7)
- Skin Microsampling, Microbiopsy (6)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (1)